Premium
Retracted: Physiologically based pharmacokinetic predictions of intestinal BCRP‐mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans
Author(s) -
Bae Soo Hyeon,
Park WanSu,
Han Seunghoon,
Park Gabjin,
Lee Jongtae,
Hong Taegon,
Jeon Sangil,
Yim DongSeok
Publication year - 2017
Publication title -
biopharmaceutics and drug disposition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.419
H-Index - 58
eISSN - 1099-081X
pISSN - 0142-2782
DOI - 10.1002/bdd.2060
Subject(s) - pharmacokinetics , telmisartan , physiologically based pharmacokinetic modelling , pharmacology , rosuvastatin , medicine , pharmacokinetic interaction , drug interaction , blood pressure
‘Physiologically based pharmacokinetic predictions of intestinal BCRP‐mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans’ by Soo Hyeon Bae, Wan‐Su Park, Seunghoon Han, Gab‐jin Park, Jongtae Lee, Taegon Hong, Sangil Jeon and Dong‐Seok Yim The above article, published online on 06 February 2017 in Wiley Online Library ( wileyonlinelibrary.com ), has been retracted by agreement between the authors, the journal Editor in Chief, K. Sandy Pang, and John Wiley & Sons, Ltd. The authors retracted the paper due to errors associated with use of log D vs. log P of telmisartan as inputs of the PBPK model. The authors concluded that there are too many changes in the article to be resolved by an Erratum, and had requested a retraction. Reference Bae, S. H., Park, W.‐S., Han, S., Park, G., Lee, J., Hong, T., Jeon, S., and Yim, D.‐S. (2016) Physiologically based pharmacokinetic predictions of intestinal BCRP‐mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans. Biopharm. Drug Dispos. , doi: 10.1002/bdd.2060 .